Related references
Note: Only part of the references are listed.Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phaseIIItrials
E. L. Simpson et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Infections in baricitinib clinical trials for patients with active rheumatoid arthritis
Kevin L. Winthrop et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis A Randomized Clinical Trial
Jonathan Silverberg et al.
JAMA DERMATOLOGY (2020)
SAFETY PROFILE OF BARICITINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS UP TO 8.4 YEARS: AN UPDATED INTEGRATED SAFETY ANALYSIS
M. C. Genovese et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study
Emma Guttman-Yassky et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment
Josef S. Smolen et al.
JOURNAL OF RHEUMATOLOGY (2019)
Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled Analysis
Lawrence F. Eichenfield et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2019)
Conjunctivitis in dupilumab clinical trials
B. Akinlade et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Efficacy and Safety of Oral Janus Kinase 1 Inhibitor Abrocitinib for Patients With Atopic Dermatitis A Phase 2 Randomized Clinical Trial
Melinda J. Gooderham et al.
JAMA DERMATOLOGY (2019)
Atopic dermatitis endotypes and implications for targeted therapeutics
Tali Czarnowicki et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Cardiovascular Safety During Treatment With Baricitinib in Rheumatoid Arthritis
Peter C. Taylor et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Association between atopic dermatitis and serious cutaneous, multiorgan and systemic infections in US adults
Shanthi Narla et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2018)
Thromboembolism with Janus Kinase (JAK) Inhibitors for Rheumatoid Arthritis: How Real is the Risk?
Ian C. Scott et al.
DRUG SAFETY (2018)
Patients with atopic dermatitis and history of eczema herpeticum elicit herpes simplex virus-specific type 2 immune responses
Stephan Traidl et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial
Katherine R. Tuttle et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study
Richard J. Silverwood et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study
Richard J. Silverwood et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Relationship of atopic dermatitis with stroke and myocardial infarction A meta-analysis
Min Yuan et al.
MEDICINE (2018)
Analysis of Spontaneous Postmarket Case Reports Submitted to the FDA Regarding Thromboembolic Adverse Events and JAK Inhibitors
Abril Verden et al.
DRUG SAFETY (2018)
The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies
Patrick M. Brunner et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Increased Risk of Cutaneous and Systemic Infections in Atopic Dermatitis-A Cohort Study
Sinead M. Langan et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder
Patrick M. Brunner et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases
Daniella M. Schwartz et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
Bacterial and Viral Infections in Atopic Dermatitis: a Comprehensive Review
Peck Y. Ong et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2016)
Risk of myocardial infarction, ischemic stroke, and cardiovascular death in patients with atopic dermatitis
Yuki M. F. Andersen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Asthma as a risk factor for zoster in adults: A population-based case-control study
Hyo Jin Kwon et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Cellular and molecular immunologic mechanisms in patients with atopic dermatitis
Thomas Werfel et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Staphylococcus aureus density on lesional and nonlesional skin is strongly associated with disease severity in atopic dermatitis
Marie Tauber et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection
Hitokazu Esaki et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Epidemiology of venous thromboembolism
John A. Heit
NATURE REVIEWS CARDIOLOGY (2015)
Epidemiology and risk factors for venous thrombosis
Mary Cushman
SEMINARS IN HEMATOLOGY (2007)
Share Paper
